1 ht, but limiting acuity loss when the fly is
still.
2 Still,
5-year overall survival (89% +/- 3% vs 90% +/- 4%
3 y mechanisms that control these responses is
still a challenge and requires tailored analyses integra
4 detection of biomarkers in tissues, which is
still a clinical challenge for minimally-invasive in viv
5 There is
still a high rate of short-term mortality and complicati
6 rization of transformation products (TPs) is
still a major concern, particularly because such TPs mig
7 terminants and their relative importance are
still a matter of debate, especially because most region
8 However, it is
still a mystery how such seemingly contradictory types o
9 There is
still a need for more studies to find the best allocatio
10 Although overall
still a rare disease, adolescent type 2 diabetes now pos
11 rough: at 1000 cd/m(2) the efficiencies were
still above 10%, which is one of the best for this type
12 rs with a variety of side-chain replacements
still accessed both the ON and OFF signaling states, sug
13 of separation by end group functionality was
still achieved on the basis of the additional dimension
14 tes were mutated, whereas DHHCs 1, 2, and 14
still activated ENaC lacking beta subunit palmitoylation
15 reated patients overall; all responders were
still alive at data cutoff.
16 They are
still alive in their 30s and 40s and show predominant at
17 odes potentially inhibitory gene products-is
still allowed to enter the cell.
18 e diamond phase ([Formula: see text]) whilst
still allowing for modest increases in lattice parameter
19 ruly live up to this challenge is, for some,
still an open question.
20 nt of excretory liver and kidney function is
still an unmet need in experimental stress models as wel
21 and its relation to the martensitic phase is
still an unresolved issue, even though it is critical to
22 strate reduction therapies are expensive and
still associated with inflammation, increased risk of ca
23 the Paris targets are realized, there could
still be a significant adaptation imperative for vulnera
24 reveal that cells refractory to invasion can
still be injected, thus extending the panel of host cell
25 in all the parameters, the test option would
still be more cost-effective than the no-test option (le
26 many forest inventory and recensus sites may
still be recovering from past disturbances, potentially
27 Priming, however, should
still be seen as only one of the tools available for lin
28 use qualitative and quantitative methods are
still being developed and the comparability of results a
29 requirements for Synaptotagmin activity are
still being elucidated.
30 se architecture, assembly, and stability are
still being investigated.
31 into this cohort is closed, but patients are
still being monitored for safety and anti-tumour activit
32 all remaining subunits, including p130/p107,
still bind to target gene promoters.
33 alysis-defective D34S aldolase mutant, which
still binds FBP, blocks AMPK activation.
34 d treatment of breast cancer, breast cancers
still cause significant mortality.
35 rophobic polychlorinated biphenyls (PCBs) is
still challenged by slow approach to equilibrium.
36 nd CPC characterization in humans in vivo is
still challenging.
37 e both CV-A24 variant and nonvariant strains
still circulate in humans, only variant strains cause AH
38 Computed tomography (CT) is
still commonly regarded as a method that causes a high r
39 severe features, a lack of functional ATM is
still compatible with early life, suggesting that adapta
40 index, large-scale ozone risk assessment is
still complicated by a large and unexplained variation i
41 ite this high degree of heterogeneity, AD is
still considered a single disease and usually treated ac
42 and regenerative processes after injury are
still controversial and insufficiently characterized.
43 nity responses to hepatitis B vaccination is
still controversial.
44 ogy, the nature of the Mg acceptor in GaN is
still controversial.
45 role in endotoxin tolerance in human DCs is
still controversial.
46 The factors explaining such similarities are
still debated, and the role played by most organismal tr
47 rather than generating NAD; however, this is
still debated.
48 nesthetic binding and channel modulation are
still debated.
49 d from the maximal coverage, this method can
still detect thousands of metabolites, allowing the anal
50 , -Gal, and -Neu5Gc), peaking at 1 month and
still detectable 1 year postinfusion.
51 f exogenous Cx30 decayed over time, but were
still detectable four weeks after canalostomy.
52 e a major loss of H3K27me3, PRC2 activity is
still detected in DIPG cells positive for H3K27M.
53 are persistent hazardous chemicals that are
still detected in the atmosphere and other environmental
54 Pulmonary vein reconnection (PVR)
still determines recurrences of atrial fibrillation afte
55 und 10%-20% of nonobese Americans and Asians
still develop NAFLD.
56 The melanoma recognition is
still difficult, and generally, relies on subjective ass
57 mplementation of multilocus model in GWAS is
still difficult.
58 ding to alpha2,6 sialosides and reduced, but
still dominant, binding to alpha2,3-linked sialic acids
59 wires for high-field-magnet applications are
still dominated by low-Tc Nb3Sn due probably to cost and
60 ion in an intradermal model of infection yet
still elicited protective immunity.IMPORTANCE The vaccin
61 molecular mechanisms of HIV-related pain are
still elusive.
62 but correlated directional swimming behavior
still emerges.
63 ling and the function of INPP5E at cilia are
still emerging.
64 Nonetheless, 61% of PLSLR samples
still exceeded 10 mug/L, reflecting the importance of im
65 position and metabolome of ccr1 ProSNBE:CCR1
still exhibited many similarities to those of ccr1 mutan
66 A gap
still exists, however, between the hardware size and rel
67 ally expressed in the hyperacute window were
still expressed in the same direction at 24 hours postin
68 Nevertheless, the system
still faces challenges in structural characteristics, in
69 tion of intact proteins, but this technology
still faces challenges.
70 Chemists are
still far from achieving the most obvious and perhaps mo
71 ventions at the signal transduction level is
still far from complete.
72 o biodiversity protection, most insights are
still focused on a single facet of biodiversity-species.
73 For instance, a pointing finger held
still for an extended period of time could aid the addre
74 In micro1 knockout cells, intracellular CCVs
still form, but acidic cluster proteins are depleted, al
75 These ideas
still frame how we understand life.
76 , a substitution degree up to four NOTAs was
still functional; (iii) circular dichroism (CD) analysis
77 ll types remained low but intermediate cells
still gave rise to basal cells, whereas basal cells divi
78 as homogenous tissue and using important yet
still generic descriptors, such as thickness (hypertroph
79 asymmetric alpha-aminoxylation reaction, and
Still-
Gennari (Z)-selective olefination reactions.
80 sence or development in patients with IPF is
still greater than expected.
81 ir growth is proportional to the area of the
still-
growing dome interior.
82 able for most patients, approximately 1 in 3
still had a poor outcome 1 year after TAVR.
83 reduction in LSM to below 13.6 kPa after SVR
still had CSPH.
84 P = .002), but patients with no chemotherapy
still had doses equivalent to five tablets per day of 5-
85 However, Symlin
still has some issues including solubility, oral bioavai
86 4 weeks of optimized treatment, the patients
still have more than 1.5 hours per day of off time.
87 vasive methods of MSCs delivery to the brain
still have to be developed.
88 However, major challenges
still have to be overcome before commercialization can b
89 contraception, the risk of breast cancer was
still higher among the women who had used hormonal contr
90 parameters are probably some of the factors
still hindering the application of graphene in commercia
91 e homology, the membrane topology of VKOR is
still in debate.
92 ome alterations on disease susceptibility is
still in its infancy, but the integration of all the abo
93 However, the field is
still in its infancy.
94 crystal growth with nanometer precision are
still in their infancy.
95 l usage and were banned only recently or are
still in use.
96 f F1 hybrid progeny, prezygotic isolation is
still incipient.
97 re their annotation and characterization are
still incomplete.
98 rial lineages, the underlying mechanisms are
still incompletely understood.
99 oss-linking proteins in cortical dynamics is
still incompletely understood.
100 ] higher permeability, but the bulk flow was
still insignificant.
101 quantitative evaluation of such feedbacks is
still insufficient.
102 Yet, we
still know little about the ecology of chytrids, their l
103 yet to be determined, or the climate models
still lack an essential component that would serve to el
104 s to the predictability of evolution, but we
still lack general insights into whether convergence is
105 about the membrane-inserted state of SecA is
still lacking and will be critical for elucidating the b
106 independent of their antibody reactivity, is
still lacking.
107 tional approach to crystallize antibodies is
still lacking.
108 ementations for macroscopic applications are
still lacking.
109 eir investigation in the clinical routine is
still lacking.
110 of paired fin development for this group is
still lacking.
111 ution in the general population in China are
still lacking.
112 s of such synthetic epigenome remodellers is
still lacking.
113 s probably important, but strong evidence is
still lacking.
114 ed prevention and therapeutic strategies are
still lacking.
115 erimental research on nodal line fermions is
still lacking.
116 th metabolites, and their genetic control is
still lacking.
117 with the trait, but large-scale analyses are
still lacking.
118 However, proteomics
still lag behind genomics in popularity and ease of use.
119 3D) assemblies based on carbon nanomaterials
still lag behind their individual one-dimensional buildi
120 d in cancer, therapeutic STAT inhibitors are
still largely absent from the clinic.
121 ontrol of the vascular inflammatory state is
still largely unclear.
122 teractions in guiding structure formation is
still largely unexplored.
123 r (PD) with and without agoraphobia (AG) are
still largely unknown and progress is hampered by small
124 However, it is
still largely unknown how gut dysbiosis affects the onse
125 n, intrinsic properties of this material are
still largely unknown.
126 ysical properties and molecular identity are
still largely unknown.
127 nisms regulating these complex processes are
still largely unknown.
128 es the potential revenue from a food that is
still largely wasted.
129 While we are
still learning more about the myriad clinical presentati
130 expensive moisturizer, the intervention was
still less than $45000/QALY.
131 c rates and development of new therapies are
still limited by a lack of knowledge of the functions an
132 ubiquitous use of this novel methodology is
still limited to soils with high organic phosphorus cont
133 logical evidence from Chinese population was
still limited.
134 s and whose experimental characterization is
still limited.
135 of (18)F-labeled tracers addressing PSMA is
still limited.
136 iled studies about the method's accuracy are
still limited.
137 of fields from biology to computer science,
still little is known about the impact of environmental
138 u mutants lacking the vesicle binding domain
still localize to the presynaptic compartment but do not
139 mote LD fusion or TAG accumulation, while it
still localizes to LDs.
140 lebs and thus migrate, though pseudopods are
still lost.
141 similar clinical activity, renumeration was
still lower for women.
142 ne methylation for synergistic effects while
still maintaining selectivity.
143 s and that comprehensive species coverage is
still many decades away.
144 ed so far and the evident success, there are
still many problems to solve, on the way to the manufact
145 sociations found were small in magnitude but
still meaningful from a child-development perspective, b
146 t experimental evidence for its existence is
still missing.
147 m, a complete picture of the E1E2 complex is
still missing.
148 he nanojet on top of a region of interest is
still missing.
149 s ago that to this day remains unsolved, but
still mystifies and intrigues.
150 ssential but that additional constraints are
still necessary to recover the observed growth rate dist
151 both the promise that now exists and what is
still needed to bring dramatic and tangible change to pa
152 registries worldwide and innovative drugs is
still needed to improve TTP management.
153 dy design, model evaluation, and methods are
still needed to mature this field.
154 l property in this aspect; however, there is
still no clear understanding of electron transport, as r
155 pidly accruing literature on CBCT, there are
still no current evidence-based guidelines on its necess
156 overed over three decades ago, but there are
still no effective therapies for Ras-driven cancers.
157 0.50 to 0.84; p = 0.001), although there was
still no significant difference in TVR between the two g
158 r accurate estimation of AAA rupture risk is
still not available.
159 However, the mechanisms are
still not clear.
160 use disastrous failure, but its mechanism is
still not completely clear.
161 and prevalence in the general population is
still not confirmed despite advances in medicine.
162 e antiretroviral treatment (HAART), HIV-1 is
still not curable due to the persistence of the HIV-1 re
163 gh the safety of these electronic devices is
still not fully known, there is evidence of their cytoto
164 ET processes that are
still not fully understood such as QD interactions with
165 details of parvovirus infection of cells are
still not fully understood, but the processes must invol
166 However, the biological mechanisms are
still not fully understood.
167 This value is
still not limited by nuclear coherence effects.
168 The nature and origin of the signal is
still not understood, but it has been recently suggested
169 ements in response to central vision loss is
still not well understood and carries importance for gai
170 rates of major depressive disorder (MDD) are
still not well understood, despite many neuroimaging stu
171 plasm and other asbestos-related diseases is
still not well understood.
172 lity of ecosystems and their biodiversity is
still not well understood.
173 ly led to LTP in PE animals, whereas LTD was
still observed in controls.
174 , 97% coverage of the myoglobin sequence was
still obtained.
175 ococcal disease (IPD), but deaths due to IPD
still occur.
176 become rarer; however, severe reactions may
still occur.
177 Human infections are
still occurring throughout Saudi Arabia at a 38% case fa
178 CRT alone, toxicity was substantial, and LRF
still occurs in approximately 20%, indicating the contin
179 Therefore, nitrones are
still of great interest and in the limelight of research
180 Instead simple dose-response models are
still often used although they only exploit data observe
181 emaining errors in the Boltzmann weights are
still on the order of a few [Formula: see text], which m
182 studies detected epithelial cells (13) , and
still others detected immune and epithelial cells (14-16
183 These studies revealed that NhaA could
still perform electrogenic Na(+)/H(+) exchange even in t
184 ated diameters larger than the slit size can
still permeate through, albeit with reduced mobility.
185 similar across viewing of dynamic videos and
still photographs.
186 The HTLV-1 particle structure is
still poorly understood, and previous studies analyzed v
187 diverse freshwater shrimp genus Caridina is
still poorly understood, despite its vast distribution -
188 tiologic factors of late-life depression are
still poorly understood.
189 ynamics and organization in motile cells are
still poorly understood.
190 wever, the underlying molecular mechanism is
still poorly understood.
191 structures in a solvent-free environment are
still poorly understood.
192 rtance among specific age and sex groups are
still poorly understood.
193 ce of tissue-specific, epigenetic pattern is
still poorly understood.
194 and yet the key events that drive aging are
still poorly understood.
195 ion, the roles of CDC42 in tumorigenesis are
still poorly understood.
196 ciple of an "energy funnel", the carotenoids
still pose many open questions.
197 in spontaneously metastasizing tumor models
still poses a challenge requiring highest sensitivity an
198 above the two-photon absorption edge, while
still possessing large nonlinearities.
199 its, including informed consent allegations,
still present a time, money, and reputation toll for phy
200 the first reexcision, positive margins were
still present in 97 patients (16.4%).
201 At 21 days, uncovered struts were
still present in the BVS group (3.8% [2.1, 10.2]).
202 ace tension was significantly lower although
still present, especially for individual derivatized ami
203 rtheless, the field of oxygen chemoreception
still presents the general observer with a bewildering a
204 h appropriate antibiotic for at least 2 days
still progressed to VAP.
205 in real-time or in a single snapshot, it is
still pushing Here, we investigated the brain systems th
206 l to regulate YAP1's nuclear localization is
still puzzling.
207 magnetization and electric polarization are
still rare.
208 dies on jets interacting with vegetation are
still rare.
209 nusual open-access copper site, yet they can
still react with superoxide at rates limited only by dif
210 nd 20 (53%) in the dose-expansion phase were
still receiving treatment.
211 However, TSB levels were
still reduced in hUGT1/Car(-/-) neonatal mice because of
212 tivity, the PiT1-PiT2 heterodimerization was
still regulated by extracellular Pi levels.
213 However, ADHD is
still relatively under-recognised and underdiagnosed in
214 hough expression of the Pap1-dependent genes
still relied on stress induction, another subset of stre
215 upon the conduction of photovoltaic current
still remain elusive.
216 om direct harmful UV rays; however, skin may
still remain exposed to reflected and indirect UV rays.
217 However, huge challenges
still remain in synthesizing whole length BsAbs, includi
218 s pertaining to the instability and toxicity
still remain that may potentially hinder their commercia
219 gnized >20 years ago, but disease mechanisms
still remain unknown.
220 although pollution levels in ICS households
still remained above WHO guidelines.
221 Nonetheless, in 2012, open surgery
still remained the preferred surgical treatment modality
222 /serum) using targeted proteomics approaches
still remains challenging, especially for these samples
223 difficile in the challenging gut environment
still remains incompletely understood.
224 Cataract
still remains the leading cause of blindness in middle-i
225 in the regulation of placental iron transfer
still remains to be characterized.
226 nishing rate of success, the major challenge
still remains to not only confirm that the genes implica
227 n planta role of most members of this family
still remains undetermined.
228 yield and agronomically relevant traits are
still required before it can become a commercially-viabl
229 M2 distal cytoplasmic domain sequences were
still required for optimal infectivity.
230 per understanding of core-shell formation is
still required.
231 rafish P450 17A1 mutant, and the active site
still resembled the structure in the other proteins, wit
232 Gillnets had a lower impact, but were
still responsible for ca. 9% of juvenile mortality on sh
233 ver, despite these defects, C9orf72 synapses
still retain the ability to express presynaptic homeosta
234 rnary molten salts CaCl2 -MgCl2 -NaCl, which
still retains high CaSiO3 solubility, and a supporting e
235 the studies is relatively small, and we are
still searching for potential diagnostic biomarkers.
236 d by reversible inactivation, animals should
still show changes in perceptual sensitivity mediated by
237 in most recombinant attenuated strains, can
still show substantial adverse or lethal actions in the
238 When compared with PCI, CABG
still showed a survival benefit (hazard ratio, 0.82; 95%
239 urity, with lower concentrations tested (7%)
still showing >80% purity for cell capture.
240 anced activity of oxygen electrocatalysts is
still somewhat controversial.
241 sociation of PID with ovarian cancer risk is
still somewhat uncertain and requires further investigat
242 lly understood because experimental data are
still sparse in that regard.
243 the brains of animals that were treated, but
still succumbed to the disease.
244 al and surgical interventions, some eyes may
still suffer this outcome.
245 year variation of spring departure dates was
still sufficient for the advancement of spring departure
246 Still,
support for this idea of concerted evolution of t
247 ng interactions continues to develop, debate
still surrounds the energetic significance and physicoch
248 Still,
the detection frequencies at follow-up were for m
249 Still,
the mitochondrial redox status did not change wit
250 ions, bare footedness, and poor housing, and
still there is a high prevalence of allergic disease.
251 The relative contributions of each are
still to be determined.
252 Still,
to date the long-term trajectories of social impa
253 ble, due to the insufficient sensitivity and
still unavailable important cross-reacting allergens.
254 xistence of intermediate-mass black holes is
still uncertain, and their formation process is therefor
255 deep ocean circulation changed, however, are
still unclear and represent a major challenge to our und
256 ulating thirst have been well studied, it is
still unclear how mammals recognize external water.
257 Nonetheless, it is
still unclear if tetravalent vaccines can elicit or reca
258 However, it is
still unclear whether these changes are related to cogni
259 The neurobiology of psychiatric disorders is
still unclear, although changes in multiple neuronal sys
260 2 enrichment on eutrophic coastal waters are
still unclear, as are the complex mechanisms coupled to
261 uit mechanism underlying this selectivity is
still unclear, but some studies have proposed that it em
262 s of preventing neuron dedifferentiation are
still unclear, especially in the optic lobe.
263 mportance in both humans and mouse models is
still unclear.
264 in DCs, although the underlying mechanism is
still unclear.
265 the genetic mechanism of ischemic stroke is
still unclear.
266 INC5 restricts HIV-1 particle infectivity is
still unclear.
267 the biological role of CCRL2 in immunity is
still unclear.
268 LCNKB mutations, and the underlying cause is
still unclear.
269 R, but how it is stimulated by DNA damage is
still unclear.
270 uence on interactions with aquatic plants is
still unclear.
271 vo relevance of the in vitro observations is
still unclear.
272 evel and role in endothelial cells (ECs) are
still unclear.
273 , but its origin at the fundamental level is
still unclear.
274 g cryoballoon ablation of pulmonary veins is
still unclear.
275 e non-sensory domains that separate them are
still unclear.
276 hly resistant to VSV, and the mechanisms are
still unclear.
277 , any association between the 2 disorders is
still unconfirmed.
278 anisms for signal reception and transfer are
still undefined.
279 ase transition (MIT), the origin of which is
still under debate.
280 TEN contributes to the understanding of this
still underinvestigated severe skin disease in a Europea
281 host lattice coupling by dopant migration is
still unexplored.
282 wever, the extended substrate specificity is
still unknown for many of these kinases.
283 omoting signals after its interaction with a
still unknown receptor(s).
284 Although the origin of these compounds is
still unknown, we present evidence that the production o
285 the origin of its immunological activity is
still unknown.
286 atelets to respond to subsequent stimuli are
still unknown.
287 er, the mechanisms driving these defects are
still unknown.
288 ognitive functioning seems preponderant, are
still unknown.
289 fire, and the long-term effects of fire are
still unknown.
290 function in neocortical pyramidal neurons is
still unknown.
291 creased height, but the causal mutations are
still unknown.
292 ns and functions of these three proteins are
still unknown.
293 s task, and its underlying sensory basis, is
still unknown.
294 hanism determining the reaction kinetics are
still unknown.
295 cells contribute to CNS antigen drainage is
still unknown.
296 induced atrophy and functional impairment is
still unsettled.
297 the spectrum of good insulating materials is
still very narrow.
298 e calcium imaging showed that the cells were
still viable.
299 ressure in host-pathogen interactions, it is
still widely assumed that genetic homology conveys simil
300 ion that cancer cells that survive treatment
still will have suffered cytotoxic stress and thereby en